Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Gastroesophageal Reflux Disease (GERD)
View Full LandscapeTarget Indication
Gastroesophageal Reflux Disease (GERD)
Clinical Trial
NCT00658528Last updated: 12/23/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Nexium Control
Nexium Control is indicated for the short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults.
View on EMA